Sydney B. Rosen, MPA

Research Professor, Global Health
Sydney Rosen
(617) 414-1273sbrosen@bu.edu
Crosstown Center – 380
View full profile at BUMC

Biography

Sydney Rosen, M.P.A., is a Research Professor in the Department of Global Health and the Center for Global Health & Development of the Boston University School of Public Health and the co-director of the Health Economics and Epidemiology Research Office (HE2RO) of the Wits Health Consortium at the University of the Witwatersrand in Johannesburg, South Africa. In collaboration with HE2RO and colleagues at BUSPH, she leads an interdisciplinary team that is carrying out a set of studies on the effectiveness, costs, and benefits of HIV/AIDS care and treatment interventions. She has also worked on other applied economics projects in the Department, including research on the economics of tuberculosis, antimicrobial resistance, malaria prevention and treatment, and air pollution. Her technical training is in public policy analysis and applied economics. She came to BUSPH in 2001 from the Health Office of the former Harvard Institute for International Development (HIID). Before joining the staff of the Health Office, she managed a set of HIID environmental policy projects in the former Soviet Union. She is also the co-founder and former executive director of WorldTeach, Inc., a nonprofit organization that places volunteer teachers in developing countries. She holds a B.A. from Harvard University and a master's degree from the Kennedy School of Government at Harvard.

Other Positions

  • Center Faculty Member, Center for Global Health & Development , Boston University School of Public Health

Education

  • Harvard University, MPA
  • Harvard University, AB

Publications

  • Published on 7/17/2017

    Long LC, Maskew M, Brennan AT, Mongwenyana C, Nyoni C, Malete G, Sanne I, Fox MP, Rosen S. Initiating antiretroviral therapy for HIV at a patient's first clinic visit: a cost-effectiveness analysis of the rapid initiation of treatment randomized controlled trial. AIDS. 2017 Jul 17; 31(11):1611-1619. PMID: 28463879.

    Read at: PubMed
  • Published on 6/15/2017

    Bor J, Ahmed S, Fox MP, Rosen S, Meyer-Rath G, Katz IT, Tanser F, Pillay D, Bärnighausen T. Effect of eliminating CD4-count thresholds on HIV treatment initiation in South Africa: An empirical modeling study. PLoS One. 2017; 12(6):e0178249. PMID: 28617805.

    Read at: PubMed
  • Published on 5/28/2017

    Rosen S, Fox MP, Larson BA, Brennan AT, Maskew M, Tsikhutsu I, Bii M, Ehrenkranz PD, Venter WF. Simplified clinical algorithm for identifying patients eligible for immediate initiation of antiretroviral therapy for HIV (SLATE): protocol for a randomised evaluation. BMJ Open. 2017 May 28; 7(5):e016340. PMID: 28554939.

    Read at: PubMed
  • Published on 4/11/2017

    Fox MP, Rosen S. A new cascade of HIV care for the era of "treat all". PLoS Med. 2017 Apr; 14(4):e1002268. PMID: 28399160.

    Read at: PubMed
  • Published on 3/23/2017

    Jamieson L, Evans D, Brennan AT, Moyo F, Spencer D, Mahomed K, Maskew M, Long L, Rosen S, Fox MP. Changes in elevated cholesterol in the era of tenofovir in South Africa: risk factors, clinical management and outcomes. HIV Med. 2017 Sep; 18(8):595-603. PMID: 28332270.

    Read at: PubMed
  • Published on 12/12/2016

    Long LC, Rosen SB, Brennan A, Moyo F, Sauls C, Evans D, Modi SL, Sanne I, Fox MP. Treatment Outcomes and Costs of Providing Antiretroviral Therapy at a Primary Health Clinic versus a Hospital-Based HIV Clinic in South Africa. PLoS One. 2016; 11(12):e0168118. PMID: 27942005.

    Read at: PubMed
  • Published on 11/3/2016

    Berhanu R, Schnippel K, Mohr E, Hirasen K, Evans D, Rosen S, Sanne I. Early Outcomes Of Decentralized Care for Rifampicin-Resistant Tuberculosis in Johannesburg, South Africa: An Observational Cohort Study. PLoS One. 2016; 11(11):e0164974. PMID: 27812140.

    Read at: PubMed
  • Published on 10/17/2016

    Gama E, Madan J, Langley I, Girma M, Evans D, Rosen S, Squire SB. Economic evaluation of a shortened standardised treatment regimen of antituberculosis drugs for patients with multidrug-resistant tuberculosis (STREAM): study protocol. BMJ Open. 2016 Oct 17; 6(10):e014386. PMID: 27798041.

    Read at: PubMed
  • Published on 9/5/2016

    Budgell EP, Evans D, Schnippel K, Ive P, Long L, Rosen S. Outcomes of treatment of drug-susceptible tuberculosis at public sector primary healthcare clinics in Johannesburg, South Africa: A retrospective cohort study. S Afr Med J. 2016 Sep 05; 106(10):1002-1009. PMID: 27725021.

    Read at: PubMed
  • Published on 8/9/2016

    Rosen S, Fox MP, Larson BA, Sow PS, Ehrenkranz PD, Venter F, Manabe YC, Kaplan J. Accelerating the Uptake and Timing of Antiretroviral Therapy Initiation in Sub-Saharan Africa: An Operations Research Agenda. PLoS Med. 2016 Aug; 13(8):e1002106. PMID: 27505444.

    Read at: PubMed

View 53 more publications:View full profile at BUMC

News & In the Media